Updated: January 1, 2026
What Is Vevye? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Everything you need to know about Vevye: what it is, what it treats, how to use it, what it costs, and what to expect from this dry eye medication in 2026.
What Is Vevye?
Vevye is a brand-name prescription eye drop approved by the FDA on May 30, 2023. Its generic name is cyclosporine ophthalmic solution 0.1%. It is distributed in the U.S. by Harrow, Inc. and was originally developed by Novaliq GmbH using their proprietary EyeSol water-free technology. Vevye is used to treat dry eye disease — a chronic condition in which the eyes don't produce enough tears or the tears evaporate too quickly, causing inflammation, discomfort, and potential damage to the eye's surface.
What Is Vevye Used For?
Vevye is FDA-approved for the treatment of the signs and symptoms of dry eye disease in adults. It is the first and only cyclosporine-based product to receive an FDA indication specifically covering both the signs (measurable clinical findings like corneal staining) and symptoms (how your eyes feel) of dry eye disease.
Common dry eye symptoms Vevye treats include: burning or stinging in the eyes, a gritty sandy feeling, redness and irritation, blurred vision that fluctuates with blinking, sensitivity to light or wind, difficulty with screen use or reading, and paradoxically watery eyes from reflex tearing.
How Does Vevye Work?
Vevye works by addressing the underlying cause of dry eye disease: inflammation. Cyclosporine is a calcineurin inhibitor — it blocks a signaling pathway that activates T-lymphocytes (immune cells) in the lacrimal glands. By reducing this inflammation, Vevye allows tear glands to function more normally and produce better-quality tears. Vevye's water-free perfluorobutylpentane vehicle is designed to enhance corneal penetration and improve tolerability compared to older aqueous-based formulations.
How Is Vevye Different from Restasis or Cequa?
- Concentration: Vevye 0.1% is higher than Cequa 0.09% and Restasis 0.05%
- Formulation: Vevye is water-free with no preservatives, no water, and no oils; Restasis is an emulsion; Cequa uses nanomicellar technology
- FDA indication: Vevye is approved for both signs AND symptoms; Restasis and Cequa are approved for increased tear production only
- Onset: Vevye shows clinical benefits as early as 15 days; Restasis may take 3-6 months for full effect
- Generic: Restasis has a generic available; Vevye and Cequa do not
Vevye Dosage: How to Use It
The standard dose is one drop in each eye twice daily, approximately 12 hours apart (for example, once in the morning and once in the evening).
Step-by-Step Instructions
- Wash your hands thoroughly before use
- If you wear contact lenses, remove them before using Vevye
- Gently pull your lower eyelid down to create a small pocket
- Tip the bottle upside down over your eye and allow one drop to fall in
- Close your eye gently — do not blink forcefully
- Do not touch the bottle tip to your eye or any surface
- Wait at least 15 minutes before reinserting contact lenses or using other eye drops
- Repeat for the other eye
How Long Does Vevye Take to Work?
Clinical benefits may begin as early as 15 days after starting treatment. Improvements in both corneal staining and patient-reported symptoms have been demonstrated in clinical trials. Full clinical benefit may continue to build over several months with consistent twice-daily use.
What Are the Side Effects?
The most common side effects in clinical trials: instillation site reactions/eye irritation (~8% of patients) and temporary decrease in visual acuity/blurred vision (~3% of patients). These are typically mild and often improve with continued use. Vevye has no boxed warnings.
How Much Does Vevye Cost?
Retail list price: approximately $900-$1,070 per 2 mL bottle (about a 30-day supply). Savings programs available:
- VEVYE Access for All (via PhilRx): $59/bottle, no prior auth, free home delivery
- VEVYE Savings Card: Potentially $0 for eligible commercially insured patients
- Medicare Part D: Covered by major plans as of January 2025
- All U.S. Medicaid programs cover Vevye
Important Precautions
- Not approved for patients under 18 years old
- Remove contact lenses before use; reinsert after 15 minutes
- Store at room temperature (59-77 degrees F); do not freeze
- Not a controlled substance
Find Vevye near you at Medfinder.com.
Also read: How does Vevye work? Mechanism of action explained
Also read: Vevye side effects: what to expect and when to call your doctor
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Vevye also looked for:
More about Vevye
29,339 have already found their meds with Medfinder.
Start your search today.





